The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Open accessAbstract
Accumulating evidence indicates that reactive oxygen species (ROS) play major roles in the initiation and progression of cardiovascular dysfunction associated with diseases such as hyperlipidemia, diabetes mellitus, hypertension, ischemic heart disease, and chronic heart failure. ROS produced by migrating inflammatory cells as well as vascular cells (endothelial cells, vascular smooth muscle cells, and adventitial fibroblasts) have distinct functional effects on each cell type. These include cell growth, apoptosis, migration, inflammatory gene expression, and matrix regulation. ROS, by regulating vascular cell function, can play a central role in normal vascular physiology, and can contribute substantially to the development of vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinn, M. T., Pagano, P. J., Johnson, C., & Alexander, R. W. (2002) · Circulation Research · doi:10.1161/01.res.0000046227.65158.f8 · Cited by 463
RetractedFree Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Self-citationAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Self-citationKu, D. N., Giddens, D. P., Zarins, C. K., & Glagov, S. (1985) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.5.3.293 · Cited by 2,707
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Cited by
Oxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Self-citationOxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Valavanidis, A., Vlachogianni, T., Fiotakis, K., & Loridas, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10093886 · Cited by 910
“pulmonary region, may be susceptible for adverse health effects of PM inhalation [88].”
BackgroundTouyz, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000138070.47616.9d · Cited by 866
Reactive oxygen species in vascular biology: implications in hypertension
Touyz, R. M., & Schiffrin, E. L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0696-7 · Cited by 646
New developments and novel therapeutic perspectives for vitamin C
Li, Y., & Schellhorn, H. E. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.10.2171 · Cited by 508
RhoA/Rho-Kinase in the Cardiovascular System
Shimokawa, H., Sunamura, S., & Satoh, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306532 · Cited by 461
Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension
Vaziri, N. D., & Rodríguez-Iturbe, B. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0283 · Cited by 442
The role of oxidative stress in the pathophysiology of hypertension
Rodrigo, R., González, J., & Paoletto, F. (2011) · Hypertension Research · doi:10.1038/hr.2010.264 · Cited by 436
Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases
Shaito, A., Aramouni, K., Assaf, R., Parenti, A., Orekhov, A., Yazbi, A. E., Pintus, G., & Eid, A. H. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703105 · Cited by 418
Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species
Azad, N., Rojanasakul, Y., & Vallyathan, V. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701436460 · Cited by 409
“Low concentrations of ROS/RNS were found to (1) activate transcription factors such as nuclear factor kappa B (NF-κB), activator protein-1 (AP-1), (2) induce apoptosis or necrosis, and (3) alter mitogenic signals that affect cell growth and cell signaling cascades ( Sauer et al, 2001 ; Taniyama & Griendling, 2003 ).”
BackgroundReactive Oxygen Species: A Key Hallmark of Cardiovascular Disease
Panth, N., Paudel, K. R., & Parajuli, K. (2016) · Advances in Medicine · doi:10.1155/2016/9152732 · Cited by 404
Angiotensin II and Vascular Injury
Montezano, A. C., Nguyen Dinh Cat, A., Rios, F. J., & Touyz, R. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0431-2 · Cited by 402
Satoh, K., Nigro, P., Matoba, T., O'Dell, M. R., Cui, Z., Shi, X., Mohan, A., Yan, C., Abe, J.-I., Illig, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1958 · Cited by 374
Reactive oxygen species signaling in vascular smooth muscle cells
CLEMPUS, R., & GRIENDLING, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.033 · Cited by 358
Self-citationHomocysteine-Induced Endothelial Dysfunction
Lai, W. K. C., & Kan, M. Y. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000437098 · Cited by 357
Acute Blood Pressure Responses in Healthy Adults During Controlled Air Pollution Exposures
Urch, B., Silverman, F., Corey, P., Brook, J. R., Lukic, K. Z., Rajagopalan, S., & Brook, R. D. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7785 · Cited by 341
Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype
Clempus, R. E., Sorescu, D., Dikalova, A. E., Pounkova, L., Jo, P., Sorescu, G. P., Lassègue, B., & Griendling, K. K. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251500.94478.18 · Cited by 334
Self-citationRoberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M., Ehdaie, A., & Vaziri, N. D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.022 · Cited by 322
“NAD(P)H oxidase is a major source of ROS in the kidney and cardiovascular tissues [27,32-35].”
BackgroundGutierrez, J., Ballinger, S. W., Darley-Usmar, V. M., & Landar, A. (2006) · Circulation Research · doi:10.1161/01.res.0000248212.86638.e9 · Cited by 318
Type 2 Diabetes Mellitus and Hypertension
Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C., & Sowers, J. R. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.005 · Cited by 307
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
NAD(P)H Oxidase Mediates TGF-β1–Induced Activation of Kidney Myofibroblasts
Bondi, C. D., Manickam, N., Lee, D. Y., Block, K., Gorin, Y., Abboud, H. E., & Barnes, J. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009020146 · Cited by 297
The potential biological mechanisms of arsenic-induced diabetes mellitus
Tseng, C.-H. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.02.009 · Cited by 296
The Role of Nrf2 in Cardiovascular Function and Disease
Satta, S., Mahmoud, A. M., Wilkinson, F. L., Yvonne Alexander, M., & White, S. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9237263 · Cited by 293
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 292
Rho-kinase: important new therapeutic target in cardiovascular diseases
Satoh, K., Fukumoto, Y., & Shimokawa, H. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2011 · Cited by 282
Angiotensin II–Induced Reactive Oxygen Species and the Kidney
Sachse, A., & Wolf, G. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020149 · Cited by 279
Diabetes and Alpha Lipoic Acid
Golbidi, S., Badran, M., & Laher, I. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00069 · Cited by 270
Yeast signaling pathways in the oxidative stress response
Ikner, A., & Shiozaki, K. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.09.006 · Cited by 267
Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension
Brown, I. A. M., Diederich, L., Good, M. E., DeLalio, L. J., Murphy, S. A., Cortese-Krott, M. M., Hall, J. L., Le, T. H., & Isakson, B. E. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311229 · Cited by 266
Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model
Moglianetti, M., De Luca, E., Pedone, D., Marotta, R., Catelani, T., Sartori, B., Amenitsch, H., Retta, S. F., & Pompa, P. P. (2016) · Nanoscale · doi:10.1039/c5nr08358c · Cited by 264
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Wei, Y., Chen, K., Whaley-Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2007 · Cited by 258
NOX5 variants are functionally active in endothelial cells
BelAiba, R. S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., Banfi, B., Hess, J., Pogrebniak, A., Bickel, C., & Görlach, A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.10.054 · Cited by 255
Schiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 253
NOX2 and NOX4 Mediate Proliferative Response in Endothelial Cells
Petry, A., Djordjevic, T., Weitnauer, M., Kietzmann, T., Hess, J., & Görlach, A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1473 · Cited by 243
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Kawahara, T., Ritsick, D., Cheng, G., & Lambeth, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501882200 · Cited by 231
Role of magnesium in hypertension
Sontia, B., & Touyz, R. M. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.05.005 · Cited by 202
Is Hypertension an Inflammatory Process?
Boos, C., & Lip, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776843313 · Cited by 165
“Under pathological conditions there an imbalance in redox state where pro-oxidants overwhelm anti-oxidant capacity leading to oxidative stress, endothelial dysfunction and reduced NO availability (with O2 - binding to NO to form ONOO-) [172, 173].”
BackgroundDevelopmental origins of cardiovascular disease: Impact of early life stress in humans and rodents
Murphy, M. O., Cohn, D. M., & Loria, A. S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.07.018 · Cited by 117
“…in cardiac contractility and peripheral vascular resistance (Reich et al., 1981) and involves vasoactive mediators such as plasma endothelin (ET-1) (Fujii et al., 2005; Kaehler et al., 2002), angiotensin II (Mayorov, 2011) and corticosterone (Taniyama and Griendling, 2003; Treiber et al., 2000).”
BackgroundCross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
MIN, L., MOGI, M., IWANAMI, J., LI, J., SAKATA, A., FUJITA, T., TSUKUDA, K., IWAI, M., & HORIUCHI, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.008 · Cited by 105
Rösen, P., & Wiernsperger, N. F. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.623 · Cited by 102
Molecular and biochemical changes of the cardiovascular system due to smoking exposure
Armani, C., Landini Jr., L., & Leone, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787846973 · Cited by 68
Ueda, S., Yamagishi, S.-I., Matsumoto, Y., Fukami, K., & Okuda, S. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0471-x · Cited by 65
Vascular dysfunction as a potential culprit of sarcopenia
Jeon, Y. K., Shin, M. J., Saini, S. K., Custodero, C., Aggarwal, M., Anton, S. D., Leeuwenburgh, C., & Mankowski, R. T. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2020.111220 · Cited by 60
Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells
Xiao, Q., Pepe, A. E., Wang, G., Luo, Z., Zhang, L., Zeng, L., Zhang, Z., Hu, Y., Ye, S., & Xu, Q. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.243188 · Cited by 56
Zhang, R., Bai, Y.-G., Lin, L.-J., Bao, J.-X., Zhang, Y.-Y., Tang, H., Cheng, J.-H., Jia, G.-L., Ren, X.-L., & Ma, J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01278.2007 · Cited by 47
Fabrication of multilayered vascular tissues using microfluidic agarose hydrogel platforms
Kinoshita, K., Iwase, M., Yamada, M., Yajima, Y., & Seki, M. (2016) · Biotechnology Journal · doi:10.1002/biot.201600083 · Cited by 46
Inhibition of human vascular nadph oxidase by apocynin derived oligophenols
Mora-Pale, M., Weïwer, M., Yu, J., Linhardt, R. J., & Dordick, J. S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.061 · Cited by 36
Gole, H. K. A., Tharp, D. L., & Bowles, D. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105337 · Cited by 36
“anion is one of the most important ROS in the vasculature [67].”
BackgroundHo, D. H., Burch, M. L., Musall, B., Musall, J. B., Hyndman, K. A., & Pollock, J. S. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00016.2016 · Cited by 34
Ewart, M.-A., Kennedy, S., MacMillan, D., Raja, A. L. N., Watt, I. M., & Currie, S. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.014 · Cited by 21
Alsaedi, A. Q., Nader, M. A., El-Kashef, D. H., & Abdelmageed, M. E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1572758 · Cited by 5
Metadata
- Authors
- Taniyama, Y., & Griendling, K. K.
- Venue
- Hypertension
- Published
- 2003-12
- Volume
- 42
- Issue
- 6
- Pages
- 1075-1081
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2168975002
- Cited by
- 1,066
- References
- 84
- FWCI
- 28.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.